Clinical Trial Update: Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel plus carboplatin followed by gemcitabine plus carboplatin for epithelial ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED